"TIANJIN TIANYAO PHARMACEUTICAL CO., LTD."Announcement on Obtaining FDA DMF First Adequate Letter for Betamethasone Dipropionate API

About this update from Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A

Announcement on Obtaining FDA DMF First Adequate Letter for Betamethasone Dipropionate APIThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A